These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Hemophilia. Current concepts in management. Green D; Smith NJ Med Clin North Am; 1972 Jan; 56(1):105-17. PubMed ID: 4550184 [No Abstract] [Full Text] [Related]
25. The optimal treatment for haemophiliacs who have developed factor VIII or -IX antibodies. Engelfriet CP; Reesink HW; Mannucci PM; Gringeri A; Ingerslev J; Brettler DB; Mauser-Bunschoten EP; Negrier C; Berntorp E; Smith OP; Shapiro AD Vox Sang; 2000; 78(4):256-61. PubMed ID: 10970234 [No Abstract] [Full Text] [Related]
26. Delivery of care to hemophilic children: home care versus hospitalization. Strawczynski H; Stachewitsch A; Morgenstern G; Shaw ME Pediatrics; 1973 Jun; 51(6):986-91. PubMed ID: 4710458 [No Abstract] [Full Text] [Related]
27. Incidence of immune responses following 102 infusions of autoplex in 18 hemophilic patients with antibody to factor VIII. Laurian Y; Girma JP; Lambert T; Meyer D; Larrieu MJ Blood; 1984 Feb; 63(2):457-62. PubMed ID: 6419798 [TBL] [Abstract][Full Text] [Related]
28. Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial. Lusher JM; Shapiro SS; Palascak JE; Rao AV; Levine PH; Blatt PM N Engl J Med; 1980 Aug; 303(8):421-5. PubMed ID: 6771653 [TBL] [Abstract][Full Text] [Related]
29. The practical management of haemophilia. Winter M Blood Rev; 1992 Sep; 6(3):174-81. PubMed ID: 1422286 [TBL] [Abstract][Full Text] [Related]
30. Laboratory evidence of DIC under FEIBA treatment of a hemophilic patient with intracranial bleeding and high titre factor VIII inhibitor. Fukui H; Fujimura Y; Takahashi Y; Mikami S; Yoshioka A Thromb Res; 1981 Apr 1-15; 22(1-2):177-84. PubMed ID: 6794176 [No Abstract] [Full Text] [Related]
34. Advances in hemophilia: experimental aspects and therapy. Rodriguez NI; Hoots WK Hematol Oncol Clin North Am; 2010 Feb; 24(1):181-98. PubMed ID: 20113902 [TBL] [Abstract][Full Text] [Related]
35. Use of FEIBA and Amicar in the operating room--dental treatment of a patient with hemophilia and high titer factor VIII inhibitors. Sharp HK; McIlveen LP; Schuman NJ Spec Care Dentist; 1986; 6(5):210-2. PubMed ID: 2945270 [No Abstract] [Full Text] [Related]
36. [Hemophilia, a changed picture]. Breederveld C; ten Cate JW; Sixma JJ; Veltkamp JJ Ned Tijdschr Geneeskd; 1976 Jan; 120(2):69-70. PubMed ID: 1250448 [No Abstract] [Full Text] [Related]
37. Choice of factor VIII/IX regimen in adolescents and young adults with severe or moderately severe haemophilia. A French national observational study (ORTHem 15-25). Meunier S; d'oiron R; Chambost H; Dolimier E; Guillet B; Thromb Res; 2017 Mar; 151():17-22. PubMed ID: 28088606 [TBL] [Abstract][Full Text] [Related]
38. Prophylaxis in patients with haemophilia: introduction. Chambost H Haemophilia; 2010 Mar; 16 Suppl 2():1-3. PubMed ID: 20132331 [No Abstract] [Full Text] [Related]
39. [Clinical effects of FEIBA on hemophilia patients with inhibitors to factor VIII or IX]. Iizuka A; Kuwashima M; Nagao T Nihon Ketsueki Gakkai Zasshi; 1982 Sep; 45(5):987-92. PubMed ID: 6818811 [No Abstract] [Full Text] [Related]